Company Overview: Mesa Laboratories, Inc.

Business Summary

Mesa Laboratories, Inc. is a global leader specializing in the design and manufacturing of life sciences tools and critical quality control solutions for regulated industries, primarily in pharmaceuticals, healthcare, and medical devices.

Core Operations & Product Divisions

1. Sterilization and Disinfection Control

• Produces biological, chemical, and cleaning indicators used to validate sterilization, decontamination, disinfection, and cleaning processes.
• Provides sterility assurance testing services mainly to dental and pharmaceutical industries.
• Product formats include biological indicators (e.g., spores on carriers, self-contained indicators, process challenge devices) and chemical indicators (color-changing for process validation).
• Markets serve hospitals, dental offices, pharmaceutical companies, medical device manufacturers, and sterilization service providers.
• Manufacturing in Montana, Germany, and the U.S.

2. Clinical Genomics

• Develops and sells high-throughput genetic analysis tools for clinical research labs and contract research organizations.
• Main product: MassARRAY® system which couples mass spectrometry with PCR enabling multiplexed analysis of up to 50 DNA variants, analyzing up to 384 samples daily.
• Key in inherited disease testing, pharmacogenetics, oncology, infectious disease, doping, and toxicology testing.
• Revenue primarily from consumables (75%) and hardware (15%), with services making up the remainder.
• Products manufactured in San Diego, California.
• Customers: Clinical and research labs, academic and government labs, mainly in the U.S. and China.

3. Biopharmaceutical Development

• Produces automated systems for protein analysis (immunoassays) and peptide synthesis.
• Products accelerate biologic drug discovery, development, and manufacturing.
• Key products: Gyrolab® xPand, Gyrolab xPlore™, Bioaffy® microfluidic disks, Rexxip® buffers, and peptide synthesizers.
• Manufacturing in Uppsala, Sweden, and Tucson, Arizona.
• Revenue composition: 35% routine consumables, 40% hardware (more discretionary), and the rest from service/support.
• Customers: Biopharmaceutical companies, contract research organizations, academic research labs.
• Significant for supporting biologics and peptide drug development.

4. Calibration Solutions

• Develops and sells quality control products for critical parameter measurement in medical device manufacturing, pharmaceuticals, hospitals, and laboratories.
• Key products include dialysate meters, gas flow calibration devices, environmental monitors, data loggers, and torque testing systems.
• Markets include dialysis facilities, medical device manufacturers, blood banks, and environmental monitoring.
• Product features: High accuracy, reliability, cloud/cloud-based alarm systems, and certification under standards like ISO, FDA, and CFR Part 11.
• Manufacturing in Colorado and Germany.

Supporting Details

• Number of Employees: 730 employees as of March 31, 2025, including approximately 500 in the U.S.
• Revenue (Fiscal Year 2025): $241 million, a growth of 11.5% from previous year.
• Net (Loss) Income (FY 2025): $(1.97) million.
• Major Customers: No single customer exceeds 10% of total revenue.
• Market Capitalization: Approximately $686 million (market value of voting stock held by non-affiliates as of September 30, 2024).
• Stock Information: Traded on Nasdaq under the symbol MLAB.
• Employees Distribution: 359 in manufacturing/quality assurance, 89 in R&D/engineering, 186 in sales/marketing, 96 in administration.
• Product Focus: Strong emphasis on high-margin, niche markets with a customer-centric, lean manufacturing approach (“The Mesa Way”).

Corporate Purpose

• Driven by their purpose of "Protecting the Vulnerable®", focusing on delivering high-quality, reliable products and safeguarding community health and safety.

This summary reflects Mesa Laboratories’ core business areas, products, markets, employee count, revenue, and strategic focus based on the provided 10-K details.